Development of a computational model of glucose toxicity in the progression of diabetes mellitus

  • Received: 01 October 2015 Accepted: 29 June 2018 Published: 01 July 2016
  • MSC : Primary: 92B05; Secondary: 92C50.

  • Diabetes mellitus is a disease characterized by a range of metabolic complications involving an individual's blood glucose levels, and its main regulator, insulin. These complications can vary largely from person to person depending on their current biophysical state. Biomedical research day-by-day makes strides to impact the lives of patients of a variety of diseases, including diabetes. One large stride that is being made is the generation of techniques to assist physicians to ``personalize medicine''.From available physiological data, biological understanding of the system, and dimensional analysis, a differential equation-based mathematical model was built in a sequential matter, to be able to elucidate clearly how each parameter correlates to the patient's current physiological state. We developed a simple mathematical model that accurately simulates the dynamics between glucose, insulin, and pancreatic -cells throughout disease progression with constraints to maintain biological relevance. The current framework is clearly capable of tracking the patient's current progress through the disease, dependent on factors such as latent insulin resistance or an attrite -cell population. Further interests would be to develop tools that allow the direct and feasible testing of how effective a given plan of treatment would be at returning the patient to a desirable biophysical state.

    Citation: Danilo T. Pérez-Rivera, Verónica L. Torres-Torres, Abraham E. Torres-Colón, Mayteé Cruz-Aponte. Development of a computational model of glucose toxicity in the progression of diabetes mellitus[J]. Mathematical Biosciences and Engineering, 2016, 13(5): 1043-1058. doi: 10.3934/mbe.2016029

    Related Papers:

    [1] Anarina L. Murillo, Jiaxu Li, Carlos Castillo-Chavez . Modeling the dynamics of glucose, insulin, and free fatty acids with time delay: The impact of bariatric surgery on type 2 diabetes mellitus. Mathematical Biosciences and Engineering, 2019, 16(5): 5765-5787. doi: 10.3934/mbe.2019288
    [2] Lingmin Lin, Kailai Liu, Huan Feng, Jing Li, Hengle Chen, Tao Zhang, Boyun Xue, Jiarui Si . Glucose trajectory prediction by deep learning for personal home care of type 2 diabetes mellitus: modelling and applying. Mathematical Biosciences and Engineering, 2022, 19(10): 10096-10107. doi: 10.3934/mbe.2022472
    [3] Kimberly Fessel, Jeffrey B. Gaither, Julie K. Bower, Trudy Gaillard, Kwame Osei, Grzegorz A. Rempała . Mathematical analysis of a model for glucose regulation. Mathematical Biosciences and Engineering, 2016, 13(1): 83-99. doi: 10.3934/mbe.2016.13.83
    [4] Micaela Morettini, Christian Göbl, Alexandra Kautzky-Willer, Giovanni Pacini, Andrea Tura, Laura Burattini . Former gestational diabetes: Mathematical modeling of intravenous glucose tolerance test for the assessment of insulin clearance and its determinants. Mathematical Biosciences and Engineering, 2020, 17(2): 1604-1615. doi: 10.3934/mbe.2020084
    [5] Edward J. Allen . Derivation and computation of discrete-delayand continuous-delay SDEs in mathematical biology. Mathematical Biosciences and Engineering, 2014, 11(3): 403-425. doi: 10.3934/mbe.2014.11.403
    [6] Abdulhadi Ibrahim H. Bima, Ayman Zaky Elsamanoudy, Walaa F Albaqami, Zeenath Khan, Snijesh Valiya Parambath, Nuha Al-Rayes, Prabhakar Rao Kaipa, Ramu Elango, Babajan Banaganapalli, Noor A. Shaik . Integrative system biology and mathematical modeling of genetic networks identifies shared biomarkers for obesity and diabetes. Mathematical Biosciences and Engineering, 2022, 19(3): 2310-2329. doi: 10.3934/mbe.2022107
    [7] Ying Zhu, Lipeng Guo, Jixin Zou, Liwen Wang, He Dong, Shengbo Yu, Lijun Zhang, Jun Li, Xueling Qu . JQ1 inhibits high glucose-induced migration of retinal microglial cells by regulating the PI3K/AKT signaling pathway. Mathematical Biosciences and Engineering, 2022, 19(12): 13079-13092. doi: 10.3934/mbe.2022611
    [8] Xiangyun Shi, Qi Zheng, Jiaoyan Yao, Jiaxu Li, Xueyong Zhou . Analysis of a stochastic IVGTT glucose-insulin model with time delay. Mathematical Biosciences and Engineering, 2020, 17(3): 2310-2329. doi: 10.3934/mbe.2020123
    [9] Lela Dorel . Glucose level regulation via integral high-order sliding modes. Mathematical Biosciences and Engineering, 2011, 8(2): 549-560. doi: 10.3934/mbe.2011.8.549
    [10] Patrick Nelson, Noah Smith, Stanca Ciupe, Weiping Zou, Gilbert S. Omenn, Massimo Pietropaolo . Modeling dynamic changes in type 1 diabetes progression: Quantifying $\beta$-cell variation after the appearance of islet-specific autoimmune responses. Mathematical Biosciences and Engineering, 2009, 6(4): 753-778. doi: 10.3934/mbe.2009.6.753
  • Diabetes mellitus is a disease characterized by a range of metabolic complications involving an individual's blood glucose levels, and its main regulator, insulin. These complications can vary largely from person to person depending on their current biophysical state. Biomedical research day-by-day makes strides to impact the lives of patients of a variety of diseases, including diabetes. One large stride that is being made is the generation of techniques to assist physicians to ``personalize medicine''.From available physiological data, biological understanding of the system, and dimensional analysis, a differential equation-based mathematical model was built in a sequential matter, to be able to elucidate clearly how each parameter correlates to the patient's current physiological state. We developed a simple mathematical model that accurately simulates the dynamics between glucose, insulin, and pancreatic -cells throughout disease progression with constraints to maintain biological relevance. The current framework is clearly capable of tracking the patient's current progress through the disease, dependent on factors such as latent insulin resistance or an attrite -cell population. Further interests would be to develop tools that allow the direct and feasible testing of how effective a given plan of treatment would be at returning the patient to a desirable biophysical state.


    [1] Accessed: 2014-04-03.
    [2] Metabolism, 61 (2012), 221-228.
    [3] 5th edition, 2002.
    [4] in Biochemistry, 5th edition, Section 21.5, W H Freeman, New York, 2002.
    [5] Journal of Clinical Investigation, 68 (1981), 1456-1467.
    [6] Journal of Clinical Investigation, 108 (2001), 655-659.
    [7] Biochem. J, 15 (1998), 19-31.
    [8] Physiological reviews, 85 (2005), 1255-1270.
    [9] Diabetes, 52 (2003), 102-110.
    [10] http://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/hyperinsulinemia/faq-20058488, Accessed: 2014-04-03.
    [11] American Journal of Physiology-Renal Physiology, 296 (2009), F298-F305.
    [12] Endocrinology, 133 (1993), 208-214.
    [13] Journal of Clinical Investigation, 50 (1971), 1702-1711.
    [14] Endocrine reviews, 19 (1998), 491-503.
    [15] Journal of Biological Chemistry, 272 (1997), 30261-30269.
    [16] Pediatric Clinics of North America, 52 (2005), 1553-1578.
    [17] Journal of Clinical Investigation, 81 (1988), 872-878.
    [18] Diabetes & metabolism, 34 (2008), S56-S64.
    [19] Applied numerical mathematics, 56 (2006), 559-573.
    [20] Diabetes, 48 (1999), 524-530.
    [21] Diabetes care, 28 (2005), S37.
    [22] http://www.healthline.com/health/diabetes/insulin-and-glucagon#Overview1, Accessed: 2014-04-03.
    [23] McGraw Hill Professional, 2012.
    [24] The American Journal of Medicine, 79 (1985), 1-7.
    [25] Diabetologia, 38 (1995), 1295-1299.
    [26] The American journal of medicine, 119 (2006), S10-S16.
    [27] Endocrinology, 143 (2002), 339-342.
    [28] Journal of Clinical Investigation, 81 (1988), 435-441.
    [29] Role of Insulin Resistance in Human Disease, 1 (1992), 91-97.
    [30] Pearson Higher Education AU, 2011.
    [31] Diabetes, 52 (2003), 581-587.
    [32] Diabetes, 53 (2004), S119-S124.
    [33] Diabetes, 43 (1994), 1085-1089.
    [34] http://healthyeating.sfgate.com/expected-blood-glucose-after-highcarb-meal-3529.html, Accessed: 2014-04-03.
    [35] http://www.phlaunt.com/diabetes/14046621.php, Accessed: 2014-04-03.
    [36] Endocrinology, 127 (1990), 1580-1589.
    [37] http://www.diabetesselfmanagement.com/managing-diabetes/blood-glucose-management/strike-the-spike-ii/, Accessed: 2014-04-03.
    [38] Molecular Systems Biology, 4 (2008), p214.
    [39] http://www.medicinenet.com/hyperglycemia/article.htm, Accessed: 2014-04-03.
    [40] Diabetes care, 23 (2000), 295-301.
    [41] Journal of the Intensive Care Society, 10 (2009), 216-217.
    [42] Journal of Theoretical Biology, 206 (2000), 605-619.
    [43] Mathematical biosciences, 235 (2012), 8-18.
    [44] Diabetes, 53 (2004), S16-S21.
    [45] Journal of Biological Chemistry, 279 (2004), 12126-12134.
    [46] Journal of Clinical Investigation, 93 (1994), 870-876.
  • This article has been cited by:

    1. Moisés Santillán, 2025, Chapter 7, 978-3-031-82395-4, 125, 10.1007/978-3-031-82396-1_7
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3706) PDF downloads(733) Cited by(1)

Article outline

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog